Algorae Pharmaceuticals Limited (LVCLF)
OTCMKTS · Delayed Price · Currency is USD
0.0079
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST
Algorae Pharmaceuticals Market Cap
Algorae Pharmaceuticals has a market cap or net worth of $25.16 million as of February 12, 2026. Its market cap has increased by 191.96% in one year.
Market Cap
25.16M
Enterprise Value
23.51M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since September 1, 2004, Algorae Pharmaceuticals's market cap has increased from 8.57M to 25.16M, an increase of 193.70%. That is a compound annual growth rate of 5.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 25.16M | 59.52% |
| Dec 31, 2025 | 15.77M | 150.64% |
| Dec 30, 2024 | 6.29M | -44.44% |
| Dec 29, 2023 | 11.32M | 8.02% |
| Dec 30, 2022 | 10.48M | 167.11% |
| Dec 30, 2021 | 3.92M | -36.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vicapsys Life Sciences | 48.56M |
| Cell Source | 43.94M |
| ZIVO Bioscience | 40.77M |
| Arch Biopartners | 39.22M |
| Harvard Apparatus Regenerative Technology | 31.65M |
| Oncotelic Therapeutics | 28.70M |
| Finch Therapeutics Group | 22.00M |
| EOM Pharmaceuticals Holdings | 17.71M |